Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong
· Delayed Price · Currency is HKD 0.800
+0.040 (5.26%)
At close: Mar 10, 2026
HKG:3737 Revenue
Zhongzhi Pharmaceutical Holdings had revenue of 880.48M CNY in the half year ending June 30, 2025, a decrease of -19.54%. This brings the company's revenue in the last twelve months to 2.01B, down -1.81% year-over-year. In the year 2024, Zhongzhi Pharmaceutical Holdings had annual revenue of 2.21B with 8.05% growth.
Revenue (ttm)
2.01B CNY
Revenue Growth
-1.81%
P/S Ratio
0.31
Revenue / Employee
806.61K CNY
Employees
2,488
Market Cap
690.88M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.21B | 164.97M | 8.05% |
| Dec 31, 2023 | 2.05B | 223.88M | 12.26% |
| Dec 31, 2022 | 1.83B | 79.44M | 4.55% |
| Dec 31, 2021 | 1.75B | 142.62M | 8.89% |
| Dec 31, 2020 | 1.60B | 261.69M | 19.50% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pak Fah Yeow International | 199.55M |
| Fusen Pharmaceutical Company | 264.08M |
| Lee's Pharmaceutical Holdings | 1.44B |
| China NT Pharma Group Company | 20.45M |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Chia Tai Enterprises International | 4.17B |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |